FLC CAPITAL ADVISORS – Eli Lilly and Company Transaction History
FLC CAPITAL ADVISORS portfolio value:
$419,000
portfolio value
FLC CAPITAL ADVISORS quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -26.49% | -467 shares | -153K | $323.35 | 1.29K |
| Q2 2022 | share | 0.00% | 0 shares | 67K | $324.23 | 1.76K | |
| Q1 2022 | share | 0.00% | 0 shares | 18K | $286.37 | 1.76K | |
| Q4 2021 | share | 0.00% | 0 shares | 80K | $277.25 | 1.76K | |
| Q3 2021 | share | 0.00% | 0 shares | 2K | $230.3 | 1.76K | |
| Q2 2021 | share | 0.00% | 0 shares | 76K | $228.04 | 1.76K | |
| Q1 2021 | share | Decrease | -5.37% | -100 shares | 14K | $184.81 | 1.76K |
| Q4 2020 | share | Increase | 0.00% | 1.86K shares | 315K | $166.32 | 1.86K |
| Q2 2020 | share | Decrease | -100.00% | -1.54K shares | -219K | $160.1 | 0 |
| Q1 2020 | share | Increase | 0.00% | 1.54K shares | 219K | $134.64 | 1.54K |